MX2018009405A - Sintesis y composicion de bibliotecas de rapafucina. - Google Patents
Sintesis y composicion de bibliotecas de rapafucina.Info
- Publication number
- MX2018009405A MX2018009405A MX2018009405A MX2018009405A MX2018009405A MX 2018009405 A MX2018009405 A MX 2018009405A MX 2018009405 A MX2018009405 A MX 2018009405A MX 2018009405 A MX2018009405 A MX 2018009405A MX 2018009405 A MX2018009405 A MX 2018009405A
- Authority
- MX
- Mexico
- Prior art keywords
- synthesis
- rapafucin
- libraries
- composition
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
- C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
- C07K17/02—Peptides being immobilised on, or in, an organic carrier
- C07K17/08—Peptides being immobilised on, or in, an organic carrier the carrier being a synthetic polymer
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/24—Immunology or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Computational Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662291437P | 2016-02-04 | 2016-02-04 | |
| PCT/US2017/016481 WO2017136708A1 (en) | 2016-02-04 | 2017-02-03 | Synthesis and composition of rapafucin libraries |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2018009405A true MX2018009405A (es) | 2018-11-09 |
Family
ID=59501078
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018009405A MX2018009405A (es) | 2016-02-04 | 2017-02-03 | Sintesis y composicion de bibliotecas de rapafucina. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US10662220B2 (https=) |
| EP (1) | EP3411413A4 (https=) |
| JP (2) | JP6891183B2 (https=) |
| CN (1) | CN108713028B (https=) |
| AU (1) | AU2017214550B2 (https=) |
| CA (1) | CA3013589A1 (https=) |
| MX (1) | MX2018009405A (https=) |
| WO (1) | WO2017136708A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202446781A (zh) | 2011-12-28 | 2024-12-01 | 日商中外製藥股份有限公司 | 胜肽化合物之製造方法 |
| EP4166664A1 (en) | 2015-03-13 | 2023-04-19 | Chugai Seiyaku Kabushiki Kaisha | Modified aminoacyl-trna synthetase and use thereof |
| US11066416B2 (en) | 2016-02-04 | 2021-07-20 | The Johns Hopkins University | Rapafucin derivative compounds and methods of use thereof |
| MX380313B (es) * | 2016-02-04 | 2025-03-12 | Univ Johns Hopkins | Rapadocinas, inhibidores de transportador 1 de nucleósido equilibrador y usos de los mismos. |
| JP6891183B2 (ja) * | 2016-02-04 | 2021-06-18 | ザ・ジョンズ・ホプキンス・ユニバーシティ | ラパフシン・ライブラリの合成と組成物 |
| US11708391B2 (en) | 2016-02-04 | 2023-07-25 | The Johns Hopkins University | Rapaglutins, novel inhibitors of GLUT and use thereof |
| JP7187323B2 (ja) | 2017-01-31 | 2022-12-12 | 中外製薬株式会社 | 無細胞翻訳系におけるペプチドの合成方法 |
| CN110869544B (zh) * | 2017-06-09 | 2024-03-08 | 中外制药株式会社 | 膜透过性高的环状肽化合物及包含其的文库 |
| WO2020163594A1 (en) | 2019-02-07 | 2020-08-13 | The Regents Of The University Of California | Immunophilin binding agents and uses thereof |
| EP3939962A4 (en) * | 2019-03-15 | 2022-12-28 | Chugai Seiyaku Kabushiki Kaisha | PROCESS FOR PREPARING AN AROMATIC AMINO ACID DERIVATIVE |
| TW202126323A (zh) | 2019-10-01 | 2021-07-16 | 約翰斯赫普金斯大學 | 雷帕弗辛（Ｒａｐａｆｕｃｉｎ）衍生化合物及其使用方法 |
| WO2021067405A1 (en) * | 2019-10-01 | 2021-04-08 | The Johns Hopkins University | Neuroprotective compounds and methods of use thereof |
| CN120271673A (zh) * | 2024-01-08 | 2025-07-08 | 重庆医科大学 | 一种化合物、包含其的药物组合物及其用途 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5798355A (en) * | 1995-06-07 | 1998-08-25 | Gpi Nil Holdings, Inc. | Inhibitors of rotamase enzyme activity |
| US5527907A (en) * | 1993-11-19 | 1996-06-18 | Abbott Laboratories | Macrolide immunomodulators |
| US5696135A (en) * | 1995-06-07 | 1997-12-09 | Gpi Nil Holdings, Inc. | Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth |
| US7056935B2 (en) | 1995-06-07 | 2006-06-06 | Gpi Nil Holdings, Inc. | Rotamase enzyme activity inhibitors |
| CN1187127A (zh) * | 1995-06-07 | 1998-07-08 | 吉尔福特药品有限公司 | 旋转异构酶活性抑制剂 |
| JP2002503667A (ja) * | 1998-02-13 | 2002-02-05 | プレジデント・アンド・フェローズ・オブ・ハーバード・カレッジ | 新規な二量体化剤、その製造および使用 |
| US6984635B1 (en) * | 1998-02-13 | 2006-01-10 | Board Of Trustees Of The Leland Stanford Jr. University | Dimerizing agents, their production and use |
| GB0417852D0 (en) | 2004-08-11 | 2004-09-15 | Biotica Tech Ltd | Production of polyketides and other natural products |
| US20080306098A1 (en) | 2006-11-06 | 2008-12-11 | Mutz Mitchell W | Pharmacokinetics of protease inhibitors and other drugs |
| JP2011524413A (ja) * | 2008-06-17 | 2011-09-01 | バイオチカ テクノロジー リミテッド | 新規化合物、及びこれらの製造のための方法 |
| US9250237B2 (en) | 2010-11-30 | 2016-02-02 | The Johns Hopkins University | Hybrid cyclic libraries and screens thereof |
| EP2607352A1 (en) * | 2011-12-22 | 2013-06-26 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Pipecolate-diketoamides for treatment of psychiatric disorders |
| EP3007696B1 (en) * | 2013-06-14 | 2019-10-16 | The Board of Regents of The University of Texas System | Novel allosteric inhibitors of proteasome and methods of use thereof |
| JP6891183B2 (ja) * | 2016-02-04 | 2021-06-18 | ザ・ジョンズ・ホプキンス・ユニバーシティ | ラパフシン・ライブラリの合成と組成物 |
-
2017
- 2017-02-03 JP JP2018540102A patent/JP6891183B2/ja active Active
- 2017-02-03 CN CN201780010182.2A patent/CN108713028B/zh active Active
- 2017-02-03 CA CA3013589A patent/CA3013589A1/en not_active Abandoned
- 2017-02-03 WO PCT/US2017/016481 patent/WO2017136708A1/en not_active Ceased
- 2017-02-03 EP EP17748264.3A patent/EP3411413A4/en active Pending
- 2017-02-03 MX MX2018009405A patent/MX2018009405A/es unknown
- 2017-02-03 AU AU2017214550A patent/AU2017214550B2/en active Active
- 2017-02-03 US US16/074,017 patent/US10662220B2/en active Active
-
2021
- 2021-05-26 JP JP2021088242A patent/JP7158532B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3411413A4 (en) | 2019-09-18 |
| EP3411413A1 (en) | 2018-12-12 |
| CN108713028A (zh) | 2018-10-26 |
| CA3013589A1 (en) | 2017-08-10 |
| JP2021138726A (ja) | 2021-09-16 |
| US10662220B2 (en) | 2020-05-26 |
| JP2019510738A (ja) | 2019-04-18 |
| JP7158532B2 (ja) | 2022-10-21 |
| CN108713028B (zh) | 2021-12-28 |
| US20190092808A1 (en) | 2019-03-28 |
| AU2017214550B2 (en) | 2024-03-07 |
| JP6891183B2 (ja) | 2021-06-18 |
| WO2017136708A1 (en) | 2017-08-10 |
| AU2017214550A1 (en) | 2018-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2018009405A (es) | Sintesis y composicion de bibliotecas de rapafucina. | |
| IL286833A (en) | Compositions containing brazzein | |
| IL282682A (en) | Improved synthesis of key intermediate of kras g12c inhibitor compound | |
| DK4021901T3 (da) | Substituerede pyridopyrimidinonylforbindelser som er nyttige som t-celleaktivatorer | |
| PL3844147T3 (pl) | Związki chemiczne | |
| DK4165024T3 (da) | Cyclobutyldihydroquinolinsulfonamid-forbindelser | |
| EP4129997A4 (en) | Octahydropyrazinodiazanaphthyridine dione compounds | |
| CL2019000992A1 (es) | Conjugados de pirrolobenzodiazepina. | |
| LT3814347T (lt) | Naftiridinono junginiai naudotini kaip t ląstelių aktyvatoriai | |
| CU20220005A7 (es) | Inhibidores tricíclicos de kars dependientes de akr1c3 | |
| CY1119585T1 (el) | Ενωσεις τετραϋδροπυρρολοθειαζινης | |
| CL2018000730A1 (es) | Compuestos heterocíclicos y usos de los mismos | |
| EA201992235A1 (ru) | Синтез ингибитора mcl-1 | |
| PT4058453T (pt) | Síntese melhorada de composto inibidor de kras g12c | |
| CL2018003132A1 (es) | Inhibidores de la arginasa y sus aplicaciones terapéuticas. | |
| EP3842412A4 (en) | BIODEGRADABLE COMPOUND, LIPID PARTICLES, COMPOSITION WITH LIPID PARTICLES AND KIT | |
| UY36151A (es) | ?una composición farmacéutica que comprende un inhibidor de fosfoinosítido 3-quinasa delta y un corticosteroide?. | |
| BR112016029333A2 (pt) | síntese de compostos de carbamoilpiridona policíclico | |
| IL310528A (en) | Pyrazolopyridinone compounds | |
| CR20180143A (es) | Nuevos compuestos biciclicos como inhibidores duales de atx/ca | |
| EP4149556C0 (en) | PEG LIPIDOIDS COMPOUNDS | |
| DK3866931T3 (da) | Forbindelser indeholdende deuterium | |
| DK3648743T3 (da) | Pressede tabletter, der omfatter nitrooxyforbindelser | |
| EA201891586A1 (ru) | Антипролиферативные соединения и их фармацевтические композиции и применения | |
| PL3405178T3 (pl) | Preparaty/kompozycje zawierające inhibitor btk |